R. Cavallo  Clinical Microbiology and Infection 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Volume 50, Issue 4, Pages (April 2009)
Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
P.-Y. Lévy  Clinical Microbiology and Infection 
Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real- time PCR findings in apparently immunocompetent patients: a case.
Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines.
Core I97L mutation in conjunction with P79Q is associated with persistent low HBV DNA and HBs antigen clearance in patients with chronic hepatitis B 
H. Lepidi, F. Gouriet, D. Raoult  Clinical Microbiology and Infection 
Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following.
Gut bacterial microbiota and obesity
C.-P. Kuo, C.-L. Wu, H.-T. Ho, C.G. Chen, S.-I. Liu, Y.-T. Lu 
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.
Atypical respiratory pathogens
J. Ambrosioni, A. Mamin, A. Hadengue, M. Bernimoulin, K. Samii, C
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies  E. Tavazzi, P. Ferrante, K.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Infectious causes of cancer: an evolving educational saga
Virological tools to diagnose and monitor hepatitis C virus infection
The microarray technology: facts and controversies
R. Cantón  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B  W.-K. Seto, D. K.-H. Wong,
Prevalence of Toscana virus antibodies in residents of Croatia
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Vector control: a cornerstone in the malaria elimination campaign
Training for the infectious diseases speciality in Norway
Retrospective study of CMV retinitis in patients with AIDS
Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels  B. Sarov, L. Novack, N.
R. Karakus, K. Caglar, C. Aybay  Clinical Microbiology and Infection 
T. Lazzarotto, B. Guerra, L. Gabrielli, M. Lanari, M.P. Landini 
Laboratory diagnosis and biosafety issues of biological warfare agents
Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitis  J. Poissy, M. Wolff, A. Dewilde, F.
Elements of design: the knowledge on which we build
S. Kurath, G. Halwachs-Baumann, W. Müller, B. Resch 
Levofloxacin in the treatment of ventilator-associated pneumonia
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus.
Metagenomics and probiotics
Hepatitis B and C virus-related carcinogenesis
Laboratory diagnosis of Clostridium difficile disease
A case of pleurisy associated with antibodies to Rickettsia conorii
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected.
New developments in laboratory monitoring of HIV-1 infection
Volume 50, Issue 4, Pages (April 2009)
Abstracts cont. Clinical Microbiology and Infection
Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
F. Ceccherini-Silberstein, V. Cento, V. Calvez, C.-F. Perno 
Immunohistochemical detection of Coxiella burnetii in an aortic graft
Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS  M. Rybicka,
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J.L. Balcázar  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

The laboratory of clinical virology in monitoring patients undergoing monoclonal antibody therapy  R. Cavallo  Clinical Microbiology and Infection  Volume 17, Issue 12, Pages 1781-1785 (December 2011) DOI: 10.1111/j.1469-0691.2011.03678.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Algorithm for the evaluation of viral infections in relation to the administration of alemtuzumab. CMV, cytomegalovirus; HBcAb, hepatitis B core antibody; HBsAb, hepatitis B surface antibody; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCV, hepatitis C virus. Clinical Microbiology and Infection 2011 17, 1781-1785DOI: (10.1111/j.1469-0691.2011.03678.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.